Study guide
10.3 Solitary Thyroid Nodule & Thyroid Carcinoma
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
10.3 Solitary Thyroid Nodule & Thyroid Carcinoma
Key Takeaways Explain This Topic AI
Solitary Thyroid Nodule (STN) evaluation begins with serum TSH; euthyroid or hypothyroid nodules require high-resolution USG followed by Fine Needle Aspiration Cytology (FNAC), which is the single best diagnostic test.
Papillary Thyroid Carcinoma (PTC) is the most common thyroid cancer (~80-85%), classically exhibiting Orphan Annie eye nuclei, Psammoma bodies, and early lymphatic dissemination to cervical lymph nodes.
Follicular Thyroid Carcinoma (FTC) cannot be diagnosed by FNAC alone because capsular or vascular invasion must be demonstrated histologically to distinguish it from benign Follicular Adenoma.
Medullary Thyroid Carcinoma (MTC) originates from parafollicular C-cells, produces calcitonin as a tumor marker, stains positive with Congo red (amyloid stroma), and is strongly linked to germline RET proto-oncogene mutations in MEN 2A/2B.
Post-thyroidectomy neck hematoma causing airway compromise requires immediate emergency bedside release of sutures and evacuation of clot prior to transferring the patient to the operating room.
Last updated: July 2026
Solitary Thyroid Nodule & Thyroid Carcinoma
Diseases of the thyroid gland represent a classic high-yield domain in UPSC CMS surgery examinations. Management demands a clear step-by-step diagnostic pathway starting from symptom evaluation to fine-needle aspiration, followed by appropriate surgical resection and postoperative oncological surveillance.
1. Approach to a Solitary Thyroid Nodule (STN)
A Solitary Thyroid Nodule is defined as a clinically palpable discrete swelling in an otherwise normal thyroid gland. Although >85% of STNs are benign (colloid nodule, adenoma, simple cyst), ruling out thyroid carcinoma is mandatory.
Clinical Red Flags Suggestive of Malignancy
Male gender or age extremes (<20 years or >60 years).
History of childhood external neck irradiation (e.g. for thymic enlargement or lymphoma).
Rapid expansion, hard/stony texture, or fixation to pre-thyroid muscles/trachea.
Presence of ipsilateral cervical lymphadenopathy (Delphian or jugulodigastric nodes).
Persistent hoarseness of voice (recurrent laryngeal nerve involvement), dyspnea, or dysphagia.
Stepwise Diagnostic Protocol
Serum TSH Level :
Low TSH (Suppressed) : Indicates hyperfunctioning nodule. Perform Radionuclide Thyroid Scan (using I-123 or Tc-99m Pertechnetate).
Hot Nodule (increased uptake): Almost universally benign (<1% risk of malignancy). Treat hyperthyroidism.
Cold Nodule (decreased uptake): 15-20% risk of malignancy; proceed to USG and FNAC.
Normal or High TSH : Proceed directly to High-Resolution Neck Ultrasound.
High-Resolution Ultrasonography (USG) : Suspicious ultrasound signs include microcalcifications, marked hypoechoicity, irregular/microlobulated margins, taller-than-wide shape (in sagittal view), and extrathyroidal extension (incorporated into TI-RADS risk stratification).
Fine Needle Aspiration Cytology (FNAC) : Investigation of Choice for evaluating thyroid nodules.
2. Bethesda System for Reporting Thyroid Cytopathology
- Bethesda Category Diagnostic Designation Risk of Malignancy Standard Management
- Bethesda I Non-diagnostic / Unsatisfactory 1 - 4% Repeat ultrasound-guided FNAC
- Bethesda II Benign (Colloid nodule, Hashimoto's) 0 - 3% Clinical & USG surveillance
- Bethesda III Atypia of Undetermined Significance (AUS / FLUS) 5 - 15% Repeat FNAC or molecular testing
- Bethesda IV Follicular Neoplasm / Suspicious for Follicular 15 - 30% Diagnostic Hemithyroidectomy / Lobectomy
- Bethesda V Suspicious for Malignancy 60 - 75% Near-total or Total Thyroidectomy
- Bethesda VI Malignant (PTC, Medullary, Anaplastic) 97 - 99% Total Thyroidectomy +/- Neck Dissection
- 3. Histopathological Types of Thyroid Carcinoma
- 1. Papillary Thyroid Carcinoma (PTC)
Frequency : Most common thyroid cancer ( 80-85% ).
Risk Factors : Head and neck ionizing radiation exposure in childhood.
Pathognomonic Microscopic Features :
Orphan Annie Eye Nuclei : Large, pale, empty-appearing optically clear nuclei with central chromatin clearing.
Psammoma Bodies : Concentrically laminated calcified structures within tumor papillae.
Nuclear Grooves and Intranuclear Cytoplasmic Pseudoinclusions .
Mode of Spread : Predominantly via lymphatics to regional cervical lymph nodes (Level VI central compartment and Levels II-V lateral compartments). Hematogenous distant spread is rare (<5%).
Prognosis : Excellent (>95% 10-year survival).
2. Follicular Thyroid Carcinoma (FTC)
Frequency : Second most common ( 10-15% ). Common in endemic iodine-deficient areas.
Diagnostic Pitfall : FNAC CANNOT differentiate Follicular Adenoma from Follicular Carcinoma because the diagnosis relies entirely on demonstrating capsular invasion or vascular invasion on histopathology. Thus, FNAC reports this as Bethesda IV (Follicular Neoplasm), necessitating lobectomy for diagnosis.
Mode of Spread : Predominantly hematogenous to bones (osteolytic, highly vascular metastases) and lungs. Lymphatic spread is rare (<5%).
3. Medullary Thyroid Carcinoma (MTC)
Origin : Arises from neuroendocrine Parafollicular C-cells derived from the neural crest (ultimobranchial body), which secrete Calcitonin .
Tumor Markers : Serum Calcitonin (used for diagnosis, post-op recurrence monitoring) and CEA .
Histology : Sheets of polygonal cells separated by amyloid stroma that stains positive with Congo Red (shows apple-green birefringence under polarized light).
Genetics : ~25% are familial, associated with MEN 2A or MEN 2B syndromes caused by germline mutations in the RET proto-oncogene . Mandatory screening of first-degree relatives for RET mutation (prophylactic total thyroidectomy indicated in carriers).
4. Anaplastic Thyroid Carcinoma
Frequency : Rare (<2%), seen in elderly patients (>65 years).
Clinical Presentation : Rapidly enlarging, stony-hard, fixed thyroid mass causing severe local compressive symptoms (stridor, dysphagia, superior vena cava syndrome).
Microscopy : Highly pleomorphic, spindle cells, giant multinucleated cells with high mitotic index.
Prognosis : Dismal; median survival <6 months. Treatment is largely palliative (tracheostomy, palliative radiotherapy).
4. Surgical Operations & Oncological Management
Lobectomy / Hemithyroidectomy : Removal of one lobe along with the isthmus. Indicated for benign nodules, low-risk micro-PTC (<1 cm unifocal), or diagnostic evaluation of Bethesda IV lesions.
Total Thyroidectomy : Complete removal of all thyroid tissue. Indicated for PTC/FTC >4 cm, bilateral tumors, extrathyroidal extension, or MTC.
Central Neck Dissection (Level VI) : Excision of pretracheal, paratracheal, and precricoid (Delphian) lymph nodes.
Postoperative Radioiodine (RAI - I-131) Ablation : Administered 4-6 weeks after total thyroidectomy to eliminate microscopic residual thyroid tissue and treat distant metastases. Requires TSH elevation (>30 mIU/L achieved by levothyroxine withdrawal or recombinant human TSH).
Levothyroxine Suppression : Post-op T4 therapy to suppress TSH below 0.1 mIU/L in high-risk patients, preventing TSH-driven tumor recurrence.
5. Post-Thyroidectomy Complications & Emergencies
Tension Hematoma (Reactionary Hemorrhage) :
Mechanism : Venous or arterial bleeding under the deep cervical fascia causing tracheal compression.
Clinical Sign : Rapid neck swelling, respiratory distress, stridor, and cyanosis within 6 hours of surgery.
Immediate Action : Emergency bedside release of skin sutures and clips to evacuate the clot and relieve airway obstruction BEFORE transfer to the OR!
Recurrent Laryngeal Nerve (RLN) Injury :
Unilateral RLN Palsy : Vocal cord assumes a paramedian position; presents with hoarseness of voice and weak cough.
Bilateral RLN Palsy : Both vocal cords assume paramedian/median positions; presents with severe airway obstruction and stridor , requiring immediate emergency endotracheal intubation or tracheostomy.
External Branch of Superior Laryngeal Nerve (EBSLN) Injury :
Innervates the cricothyroid muscle (tenses vocal cords). Transection during upper pole ligation leads to loss of high-pitched voice and voice fatigue (Gall-Curci nerve).
Postoperative Hypocalcemia / Tetany :
Caused by inadvertent removal or ischemic necrosis of parathyroid glands.
Signs: Circumoral numbness, tingling of fingertips, Chvostek's sign (twitching of facial muscles on tapping facial nerve), and Trousseau's sign (carpopedal spasm induced by inflating BP cuff above systolic pressure for 3 mins).
Treatment: Acute tetany managed with IV Calcium Gluconate (10 ml of 10% solution) over 10 minutes.